Search results :

LY146032

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01XX09

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Gastrointestinal disorder Gastrointestinal disorder postmarketing — 50% - 58.6% x x x x x x x x x
Infection Infection postmarketing, 48.3% - 54.2% x x x x x x x
Infestation Infestation NOS postmarketing, 48.3% - 54.2% x x x x x x x x
Mediastinal disorder Mediastinal disorder postmarketing, 31.7% - 37.1% x x x x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing — 30% - 34.5% x x x x x x x
Connective tissue disorder Connective tissue disorder postmarketing, 29.2% - 36.2% x x x x x x x
Nervous system disorder Nervous system disorder postmarketing — 26.7% - 27.6% x x x x x x x x x
Mental disorder Mental disorder postmarketing — 24.1% - 29.2% x x x x x x x x
Malnutrition Malnutrition uncommon, 21.7% - 32.8% x x x x x x x
Angiopathy Angiopathy postmarketing — 17.2% - 17.5% x x x x x x x x x
Urethral disorder Urinary tract disorder postmarketing — 15% - 22.4% x x x x x x x x
Urinary tract disorder Urinary tract disorder postmarketing — 15% - 22.4% x x x x x x x x
Hypokalaemia Hypokalaemia 9.17% - 12.9% x x x x x x
Oedema peripheral Oedema peripheral 6.67% - 13.8% x x x x x
Nausea Nausea postmarketing — 1.7% - 19.8% x x x x x x x x x
Back pain Back pain 6.67% - 8.62% x x x x x x
Constipation Constipation postmarketing — 6.2% - 12.1% x x x x x x x x
Hyperkalaemia Hyperkalaemia 5% - 8.62% x x x x x
Injection site reaction Injection site reaction 5.8% - 7.7% x x x x x x
Eye disorder Eye disorder 4.2% - 8.6% x x x x x x
Pleural effusion Pleural effusion 5.8% - 6.9% x x x x x
Cardiac disorder Cardiac disorder postmarketing — 11.7% - 15.5% x x x x x x x x
Chest pain Chest pain 0% - 6.7% x x x x x x x
Osteomyelitis Osteomyelitis 5.8% - 6.03% x x x x x
Pneumonia Pneumonia 3.3% - 7.8% x x x x x
Oedema Oedema 4.3% - 6.7% x x x x x x x
Headache Headache postmarketing — 5.4% - 10.3% x x x x x x x x x
Insomnia Insomnia postmarketing — 4.5% - 9.2% x x x x x x x x x
Diarrhoea Diarrhoea postmarketing — 1.7% - 18.1% x x x x x x x x x
Loose stools 1.7% - 5.2% x x x x x
Laryngeal pain Pharyngolaryngeal pain 1.7% - 8.33% x x x x x x
Anxiety Anxiety postmarketing — 5% - 5.2% x x x x x x x x
Asthenia Asthenia postmarketing — 5% - 5.2% x x x x x x x x x
Fatigue postmarketing, uncommon x x x x x x x x x
Erythema Erythema postmarketing, 5% - 5.2% x x x x x x
Infusion site reaction Infusion site reaction common x
Dermatitis Rash postmarketing — 2.5% - 8.62% x x x x x x x x x
Rash Rash postmarketing — 2.5% - 8.62% x x x x x x x x x
Injection site erythema Injection site erythema 2.5% - 6.03% x x x x x
Abdominal pain Abdominal pain postmarketing — 3.4% - 5.83% x x x x x x x x x
Gastrointestinal pain Abdominal pain postmarketing — 3.4% - 5.83% x x x x x x x x x
Pruritus Pruritus postmarketing — 2.8% - 5.83% x x x x x x x x x
Vomiting Vomiting postmarketing — 1% - 12.9% x x x x x x x x x
Sepsis Sepsis 2.59% - 5% x x x x x x
Gastrointestinal haemorrhage Gastrointestinal haemorrhage 1.67% - 5.2% x x x x x
Cough Cough postmarketing, 3.3% - 6.03% x x x x x x x x x
Renal failure acute Renal failure acute 0% - 6.03% x x x x x
Fungal infection Fungal infection postmarketing — 2.6% - 3.2% x x x x x x x x
Breast disorder Breast disorder postmarketing — 5% - 6.9% x x x
Renal failure Renal failure postmarketing — 1.7% - 9.5% x x x x x x x x
Renal impairment postmarketing — 1% - 1.7% x x x x x x x x
Flatulence Flatulence postmarketing, common x x x x x x x x
Abdominal bloating postmarketing, common x x
Abdominal distension Abdominal bloating postmarketing, common x x
Abdominal distension x x x x x x x
Bacteraemia Bacteraemia 0% - 5% x x x x x x
Dyspepsia Dyspepsia postmarketing — 1% - 6.9% x x x x x x x x
Body temperature increased Body temperature increased postmarketing — 0% - 8.62% x x x x x x x x
Hyperhidrosis Sweating increased 0% - 5% x x x x x x
Hypotension Hypotension postmarketing — 0% - 7.8% x x x x x x x x x
Urinary tract infection Urinary tract infection postmarketing — 0.5% - 9.5% x x x x x x x x x
Anaemia Anaemia postmarketing — 2.1% - 15.5% x x x x x x x x
Blood creatine phosphokinase increased Creatine phosphokinase increased 1.8% - 2.8% x x x x x x x
Blood creatine phosphokinase increased 1% - 6.7% x x x x x x
Hypertension Hypertension postmarketing — 1.1% - 5.83% x x x x x x x x x
Arthralgia Arthralgia postmarketing — 0% - 11.2% x x x x x x x x x
Musculoskeletal discomfort Arthralgia postmarketing — 0% - 11.2% x x x x x x x x x
Myalgia postmarketing — 1% x x x x x x x x x
Dizziness Dizziness postmarketing — 2% - 6.03% x x x x x x x x x
Syncope postmarketing x
Dyspnoea Dyspnoea postmarketing, 1.6% - 5.2% x x x x x x x
Pain in extremity Pain in extremity postmarketing — 1.5% - 9.5% x x x x x x x x
Vulvovaginal candidiasis Vaginal moniliasis 0% - 1.7% x x x x x x
Vulvovaginal mycotic infection Vaginal moniliasis 0% - 1.7% x x x x x x
Eosinophilia Eosinophilia postmarketing — 0% - 1.7% x x x x x x x x x
Liver function test abnormal Liver function test abnormal postmarketing — 1% - 3% x x x x x x x x x
Blood alkaline phosphatase increased Blood alkaline phosphatase increased 0% - 1.7% x x x x x x
Phosphatase alkaline increased x x x x x x
International normalised ratio increased International normalised ratio increased 0% - 1.7% x x x x
Blood phosphorus increased Blood phosphorus increased 1% - 2.5% x
Dysgeusia Dysgeusia 0% - 2.6% x x x x x x x
Taste metallic postmarketing x
Candida infection Candida infection postmarketing — 0% - 1.7% x x x x x x x x x
Oral candidiasis 1% x x x x x x
Muscular weakness Limb paresis 0% - 1.7% x
Muscular weakness postmarketing, uncommon x x x x x x x x x
Monoparesis Limb paresis 0% - 1.7% x
Bone disorder Bone disorder uncommon x
Chills Chills uncommon x
Rigors postmarketing x x x x x x x x
Blood creatinine increased Blood creatinine increased uncommon, 0% - 2.6% x x
Serum creatinine increased postmarketing x
Electrolyte imbalance Electrolyte imbalance uncommon x
Arrhythmia supraventricular Arrhythmia supraventricular uncommon x x x x x x x x
Atrial fibrillation Atrial fibrillation 1% x x x x x x
Atrial flutter Atrial flutter 1% x x x x x x
Oral candidiasis Oral candidiasis 1% x x x x x x
Dyskinesia Dyskinesia 1% x x x x x x
Cardiac arrest Cardiac arrest 1% x x x x x x
Paraesthesia Paraesthesia postmarketing — 1% x x x x x x x x x
Proteinuria Proteinuria 1% x x x x x x
Protein urine present Proteinuria 1% x x x x x x
Thrombocytopenia Thrombocytopenia 1% x x x x x x x
Tinnitus Tinnitus 1% x x x x x x
Dry mouth Dry mouth 1% x x x x x x
Fungaemia Fungaemia postmarketing — 1% x x x x x x x x
Prothrombin level increased Prothrombin level increased postmarketing, 1% x x x x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased 1% x x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased postmarketing — 1% x x x x x x x x
Miliaria Miliaria rubra 1% x x x x x
Rash vesicular Rash vesicular 1% x x x x x x
Myalgia Myalgia postmarketing — 1% x x x x x x x x x
Gingival pain Gingival pain 1% x x x x x x
Vision blurred Vision blurred 1% x x x x x x
Pruritus generalised Pruritus generalised 1% x x x x x x
Lymphadenopathy Lymphadenopathy 1% x x x x x x
Hypoaesthesia oral Hypoaesthesia oral 1% x x x x x x
Thrombocytosis Thrombocytosis postmarketing — 1% x x x x x x x x x
Urinary tract infection fungal Urinary tract infection fungal 1% x x x x x x
Epigastric discomfort Epigastric discomfort 1% x x x x x x
Renal impairment Renal impairment postmarketing — 1% - 1.7% x x x x x x x x
Function kidney decreased x x x x x
Fatigue Fatigue postmarketing, uncommon x x x x x x x x x
Hyperglycaemia Hyperglycaemia postmarketing, uncommon x x x x x x x x
Tremor Tremor postmarketing, uncommon x x
Vaginal inflammation Vaginal inflammation postmarketing, uncommon x x
Vaginal infection Vaginal inflammation postmarketing, uncommon x x
Decreased appetite Decreased appetite postmarketing, uncommon x x x x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing, uncommon x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x x x x x
Angioedema Angioedema postmarketing x x x
Dysphagia Dysphagia postmarketing x x x x x x
Drug eruption Drug eruption postmarketing x x x
Flushing Flushing postmarketing, uncommon x x x x x x x x x
Glossitis Glossitis postmarketing x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x
Immune system disorder Immune system disorder postmarketing x x x x x x x x
Jaundice Jaundice postmarketing, rare x x x x x x x x x
Myopathy Myopathy postmarketing x x x
Musculoskeletal disorder Musculoskeletal disorder postmarketing x x x x x x x
Myositis Myositis postmarketing x
Pain Pain postmarketing x
Neuropathy peripheral Neuropathy peripheral postmarketing x x x
Pulmonary eosinophilia Pulmonary eosinophilia postmarketing x x x x x x
Rhabdomyolysis Rhabdomyolysis postmarketing x x x x x x x x
Erythema multiforme Stevens-Johnson syndrome postmarketing x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x
Shock Syncope postmarketing x
Syncope Syncope postmarketing x
Loss of consciousness Syncope postmarketing x
Tachycardia Tachycardia postmarketing x
Supraventricular tachycardia Supraventricular tachycardia postmarketing x
Urticaria Urticaria postmarketing, uncommon x x x x x x x x
Vertigo Vertigo postmarketing, uncommon x x x x x x x x x
Wheezing Wheezing postmarketing x
Rash pustular Vesiculobullous rash postmarketing x x
Dermatitis bullous Vesiculobullous rash postmarketing x x
Extrasystoles Extrasystoles postmarketing x
Transaminases increased Transaminases increased postmarketing x
Drug interaction Drug interaction postmarketing x
Oropharyngeal swelling Oropharyngeal swelling postmarketing x
Eosinophilic pneumonia Eosinophilic pneumonia postmarketing x x x
Cellulitis Cellulitis x x x x x x
Cholangitis Cholangitis x x x x x
Coma Coma x
Confusional state Confusional state x x x x x x
Feeling abnormal Confusional state x x x x x x
Crohn's disease Crohn's disease x x x x x
Eczema Eczema x x x x x x x
Hallucination Hallucination x x x x x x
Cardiac failure Cardiac failure x x x x x x
Hypoglycaemia Hypoglycaemia x x x x x x
Leukocytosis Leukocytosis x x x x x x x
Lymphatic disorder Lymphatic disorder x x x x x x
Mediastinitis Mediastinitis x x x x x
Muscle spasms Cramp muscle x x x x x x x
Stomatitis Stomatitis x x x x x x x
Urosepsis Urosepsis x x x x x
Hypomagnesaemia Hypomagnesaemia x x x x x x x
Blood lactate dehydrogenase increased Lactic dehydrogenase activity increased x x x x x x
Discomfort Discomfort x x x x x x
Eye irritation Eye irritation x x x x x x x
Intestinal infarction Intestinal infarction x x x x x
Oropharyngeal discomfort Throat sore x x x x x x
Oropharyngeal pain Throat sore x x x x x x
Staphylococcal infection Methicillin-resistant Staphylococcus aureus infection x
Alcoholic pancreatitis Alcoholic pancreatitis x x x x x
Nervousness Feeling jittery x x x x x x
Feeling jittery Feeling jittery x x x x x x
Blood bicarbonate increased Serum bicarbonate increased x x x x x x x
Staphylococcal bacteraemia Staphylococcus aureus bacteremia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

daptomycin / CUBICIN

Side effects:75
Source:medicines.org.au

daptomycin / daptomycin

Side effects:84
Source:EMA

DAPTOMYCIN / CUBICIN

Side effects:71
Source:FDA

Daptomycin

Side effects:112
Source:FDA Structured Product Label

DAPTOMYCIN / CUBICIN

Side effects:135
Source:FDA

DAPTOMYCIN / CUBICIN

Side effects:136
Source:FDA

DAPTOMYCIN / CUBICIN

Side effects:136
Source:FDA

DAPTOMYCIN / CUBICIN

Side effects:137
Source:FDA

DAPTOMYCIN / CUBICIN

Side effects:138
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label